Herpes simplex virus infections

Infectious Diseases of the Fetus and Newborn: Expert Consult - Online and Print

Volumn , Issue , 2010, Pages 813-833

  Gutierrez, Kathleen M ^a   Whitley, Richard J ^b   Arvin, Ann M ^a  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85133904524     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-6400-8/00026-2     Document Type: Chapter

References (153)

1. Hass M. Hepataadrenal necrosis with intranuclear inclusion bodies: report of a case. Am. J. Pathol. 1935, 11:127.
2. Batignani A. Conjunctivite da virus erpeticoin neonato. Boll. Ocul. 1934, 13:1217.
3. Nahmias A., Dowdle W.R. Antigenic and biological differences in herpesvirus hominis. Prog. Med. Virol. 1968, 10:110-159.
4. Roizman B., Knipe D.M., Whitley R.J. Herpes simplex viruses. Fields Virology 2007, Lippincott Williams & Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
5. Spear P.G. Glycoproteins of herpes simplex virus. Viral Fusion Mechanisms 1993, CRC Press, Boca Raton, FL. J. Bentz (Ed.).
6. Roizman B., et al. Identification and preliminary mapping with monoclonal antibodies of a herpes simplex virus 2 glycoprotein lacking a known type 1 counterpart. Virology 1984, 133:242-247.
7. Roizman B., Jenkins F.J. Genetic engineering of novel genomes of large DNA viruses. Science 1985, 229:1208-1214.
8. York I.A., et al. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 1994, 77:525-535.
9. Jugovic P., et al. Inhibition of major histocompatibility complex class I antigen presentation in pig and primate cells by herpes simplex virus type 1 and 2 ICP47. J. Virol. 1998, 72:5076-5084.
10. Sullender W.M., et al. Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes. J. Infect. Dis. 1988, 157:164-171.
11. Coleman R.M., et al. Determination of herpes simplex virus type-specific antibodies by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 1983, 18:287-291.
12. Wald A., Ashley-Morrow R. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection. Clin. Infect. Dis. 2002, 35(Suppl. 2):S173-S182.
13. Ashley R.L., et al. Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies. J. Clin. Microbiol. 1998, 36:294-295.
14. Cushing H. Surgical aspects of major neuralgia of trigeminal nerve: report of 20 cases of operation upon the gasserian ganglion with anatomic and physiologic notes on the consequence of its removal. JAMA 1905, 44.
15. Goodpasture E.W. Herpetic infections with special reference to involvement of the nervous system. Medicine 1929, 8.
16. Carton C.A., Kilbourne E.D. Activation of latent herpes simplex by trigeminal sensory-root section. N. Engl. J. Med. 1952, 246.
17. Pazin G.J., et al. Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root. N. Engl. J. Med. 1979, 301:225-230.
18. Cunningham A.L., et al. The cycle of human herpes simplex virus infection: virus transport and immune control. J. Infect. Dis. 2006, 194(Suppl. 1):S11-S18.
19. Stevens J.G., Cook M.L. Latent herpes simplex virus in spinal ganglia of mice. Science 1971, 173:843-845.
20. Rock D.L., Fraser N.W. Detection of HSV-1 genome in central nervous system of latently infected mice. Nature 1983, 302:523-525.
21. Baringer J.R. Recovery of herpes simplex virus from human sacral ganglions. N. Engl. J. Med. 1974, 291:828-830.
22. Xu F., et al. Seroprevalence of herpes simplex virus type 1 in children in the United States. J. Pediatr. 2007, 151:374-377.
23. Xu F., et al. Seroprevalence of herpes simplex virus types 1 and 2 in pregnant women in the United States. Am. J. Obstet. Gynecol. 2007, 196:43e1. 43e6.
24. Wentworth B.B., Alexander E.R. Seroepidemiology of infectious due to members of the herpesvirus group. Am. J. Epidemiol. 1971, 94:496-507.
25. Arvin A.M. The epidemiology of perinatal herpes simplex infections. Genital and Neonatal Herpes 1996, John Wiley & Sons, New York. L. Stanberry (Ed.).
26. Nahmias A.J., et al. Antibodies to Herpesvirus hominis types 1 and 2 in humans. I. Patients with genital herpetic infections. Am. J. Epidemiol. 1970, 91:539-546.
27. Lafferty W.E., et al. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J. Infect. Dis. 2000, 181:1454-1457.
28. Xu F., et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006, 296:964-973.
29. Wald A., et al. Virologic characteristics of subclinical and symptomatic genital herpes infections. N. Engl. J. Med. 1995, 333:770-775.
30. Frenkel L.M., et al. Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes. Ann. Intern. Med. 1993, 118:414-418.
31. Fleming D.T., et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N. Engl. J. Med. 1997, 337:1105-1111.
32. Smith J.S., Robinson N.J. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J. Infect. Dis. 2002, 186(Suppl. 1):S3-S28.
33. Buchman T.G., Roizman B., Nahmias A.J. Demonstration of exogenous genital reinfection with herpes simplex virus type 2 by restriction endonuclease fingerprinting of viral DNA. J. Infect. Dis. 1979, 140:295-304.
34. Schmidt O.W., Fife K.H., Corey L. Reinfection is an uncommon occurrence in patients with symptomatic recurrent genital herpes. J. Infect. Dis. 1984, 149:645-646.
35. Lakeman A.D., Nahmias A.J., Whitley R.J. Analysis of DNA from recurrent genital herpes simplex virus isolates by restriction endonuclease digestion. Sex. Transm. Dis. 1986, 13:61-66.
36. Boucher F.D., et al. A prospective evaluation of primary genital herpes simplex virus type 2 infections acquired during pregnancy. Pediatr. Infect. Dis. J. 1990, 9:499-504.
37. Brown Z.A., et al. Genital herpes in pregnancy: risk factors associated with recurrences and asymptomatic viral shedding. Am. J. Obstet. Gynecol. 1985, 153:24-30.
38. Prober C.G., et al. Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus. N. Engl. J. Med. 1988, 318:887-891.
39. Kulhanjian J.A., et al. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N. Engl. J. Med. 1992, 326:916-920.
40. Brown Z.A., et al. Effects on infants of a first episode of genital herpes during pregnancy. N. Engl. J. Med. 1987, 317:1246-1251.
41. Brown Z.A., et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N. Engl. J. Med. 1991, 324:1247-1252.
42. Flewett T.H., Parker R.G., Philip W.M. Acute hepatitis due to Herpes simplex virus in an adult. J. Clin. Pathol. 1969, 22:60-66.
43. Young E.J., Killam A.P., Greene J.F. Disseminated herpesvirus infection: association with primary genital herpes in pregnancy. JAMA 1976, 235:2731-2733.
44. Hensleigh P.A., et al. Genital herpes during pregnancy: inability to distinguish primary and recurrent infections clinically. Obstet. Gynecol. 1997, 89:891-895.
45. Nahmias A.J., et al. Perinatal risk associated with maternal genital herpes simplex virus infection. Am. J. Obstet. Gynecol. 1971, 110:825-837.
46. Brown Z.A., et al. The acquisition of herpes simplex virus during pregnancy. N. Engl. J. Med. 1997, 337:509-515.
47. Dietrich Y.M., Napolitano P.G. Acyclovir treatment of primary herpes in pregnancy complicated by second trimester preterm premature rupture of membranes with term delivery: case report. Am. J. Perinatol. 2002, 19:235-238.
48. Arvin A.M., et al. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. N. Engl. J. Med. 1986, 315:796-800.
49. Prober C.G., et al. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. N. Engl. J. Med. 1987, 316:240-244.
50. Whitley R.J., et al. Changing presentation of herpes simplex virus infection in neonates. J. Infect. Dis. 1988, 158:109-116.
51. Corey L., et al. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann. Intern. Med. 1983, 98:958-972.
52. Johnston C., et al. Herpes simplex virus viremia during primary genital infection. J. Infect. Dis. 2008, 198:31-34.
53. Yeager A.S., et al. Relationship of antibody to outcome in neonatal herpes simplex virus infections. Infect. Immun. 1980, 29:532-538.
54. Sullender W.M., et al. Humoral and cell-mediated immunity in neonates with herpes simplex virus infection. J. Infect. Dis. 1987, 155:28-37.
55. ACOG Practice Bulletin Clinical management guidelines for obstetrician-gynecologists. No. 82 June 2007. Management of herpes in pregnancy. Obstet. Gynecol. 2007, 109:1489-1498.
56. Brown Z.A., et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003, 289:203-209.
57. Stone K.M., et al. National surveillance for neonatal herpes simplex virus infections. Sex. Transm. Dis. 1989, 16:152-156.
58. Kaye E.M., Dooling E.C. Neonatal herpes simplex meningoencephalitis associated with fetal monitor scalp electrodes. Neurology 1981, 31:1045-1047.
59. Parvey L.S., Ch'ien L.T. Neonatal herpes simplex virus infection introduced by fetal-monitor scalp electrodes. Pediatrics 1980, 65:1150-1153.
60. Sullivan-Bolyai J., et al. Neonatal herpes simplex virus infection in King County, Washington: increasing incidence and epidemiologic correlates. JAMA 1983, 250:3059-3062.
61. Gutierrez K.M., et al. The epidemiology of neonatal herpes simplex virus infections in California from 1985 to 1995. J. Infect. Dis. 1999, 180:199-202.
62. Morris S.R., et al. Neonatal herpes morbidity and mortality in California, 1995-2003. Sex. Transm. Dis. 2008, 35:14-18.
63. Xu F., et al. Incidence of neonatal herpes simplex virus infections in two managed care organizations: implications for surveillance. Sex. Transm. Dis. 2008, 35:592-598.
64. Gaytant M.A., et al. [Incidence of herpes neonatorum in Netherlands]. Ned. Tijdschr. Geneeskd. 2000, 144:1832-1836.
65. Caviness A.C., et al. The prevalence of neonatal herpes simplex virus infection compared with serious bacterial illness in hospitalized neonates. J. Pediatr. 2008, 153:164-169.
66. Baldwin S., Whitley R.J. Intrauterine herpes simplex virus infection. Teratology 1989, 39:1-10.
67. Florman A.L., et al. Intrauterine infection with herpes simplex virus: resultant congenital malformations. JAMA 1973, 225:129-132.
68. Hutto C., et al. Intrauterine herpes simplex virus infections. J. Pediatr. 1987, 110:97-101.
69. South M.A., et al. Congenital malformation of the central nervous system associated with genital type (type 2) herpesvirus. J. Pediatr. 1969, 75:13-18.
70. Kahlon J., Whitley R.J. Antibody response of the newborn after herpes simplex virus infection. J. Infect. Dis. 1988, 158:925-933.
71. Garcia A.G. Maternal herpes-simplex infection causing abortion: histopathologic study of the placenta. Hospital (Rio J) 1970, 78:1267-1274.
72. Arvin A.M. Fetal and neonatal infections. Viral Pathogenesis 1996, Lippincott-Raven, New York. N. Nathanson, F. Murphy (Eds.).
73. Alanen A., Hukkanen V. Herpes simplex virus DNA in amniotic fluid without neonatal infection. Clin. Infect. Dis. 2000, 30:363-367.
74. Kimberlin D.W., et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001, 108:223-229.
75. Douglas J., Schmidt O., Corey L. Acquisition of neonatal HSV-1 infection from a paternal source contact. J. Pediatr. 1983, 103:908-910.
76. Hammerberg O., et al. An outbreak of herpes simplex virus type 1 in an intensive care nursery. Pediatr. Infect. Dis. 1983, 2:290-294.
77. Light I.J. Postnatal acquisition of herpes simplex virus by the newborn infant: a review of the literature. Pediatrics 1979, 63:480-482.
78. Linnemann C.C., et al. Transmission of herpes-simplex virus type 1 in a nursery for the newborn: identification of viral isolates by D.N.A. "fingerprinting". Lancet 1978, 1:964-966.
79. Yeager A.S., Ashley R.L., Corey L. Transmission of herpes simplex virus from father to neonate. J. Pediatr. 1983, 103:905-907.
80. Sullivan-Bolyai J.Z., et al. Disseminated neonatal herpes simplex virus type 1 from a maternal breast lesion. Pediatrics 1983, 71:455-457.
81. Hatherley L.I., Hayes K., Jack I. Herpes virus in an obstetric hospital. II. Asymptomatic virus excretion in staff members. Med. J. Aust. 1980, 2:273-275.
82. Hatherley L.I., Hayes K., Jack I. Herpes virus in an obstetric hospital. III. Prevalence of antibodies in patients and staff. Med. J. Aust. 1980, 2:325-329.
83. Burchett S.K., et al. Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection. J. Infect. Dis. 1992, 165:813-818.
84. Chilmonczyk B.A., et al. Characterization of the human newborn response to herpesvirus antigen. J. Immunol. 1985, 134:4184-4188.
85. Kohl S., Harmon M.W. Human neonatal leukocyte interferon production and natural killer cytotoxicity in response to herpes simplex virus. J. Interferon. Res. 1983, 3:461-463.
86. Kohl S., et al. Neonatal antibody-dependent cellular cytotoxic antibody levels are associated with the clinical presentation of neonatal herpes simplex virus infection. J. Infect. Dis. 1989, 160:770-776.
87. Pass R.F., et al. Specific lymphocyte blastogenic responses in children with cytomegalovirus and herpes simplex virus infections acquired early in infancy. Infect. Immun. 1981, 34:166-170.
88. Kohl S. Neonatal herpes simplex virus infection. Clin. Perinatol. 1997, 24:129-150.
89. Mintz L., et al. Age-dependent resistance of human alveolar macrophages to herpes simplex virus. Infect. Immun. 1980, 28:417-420.
90. Hirsch M.S., Zisman B., Allison A.C. Macrophages and age-dependent resistance to Herpes simplex virus in mice. J. Immunol. 1970, 104:1160-1165.
91. Diamond C., et al. Viremia in neonatal herpes simplex virus infections. Pediatr. Infect. Dis. J. 1999, 18:487-489.
92. Kawada J., et al. Evaluation of systemic inflammatory responses in neonates with herpes simplex virus infection. J. Infect. Dis. 2004, 190:494-498.
93. Singer D.B. Pathology of neonatal Herpes simplex virus infection. Perspect. Pediatr. Pathol. 1981, 6:243-278.
94. Whitley R., et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N. Engl. J. Med. 1991, 324:450-454.
95. Nahmias A. Infection of the newborn with herpesvirus hominis. Adv. Pediatr. 1970, 17:185-226.
96. Whitley R.J., Kimberlin D.W. Infections in perinatology: antiviral therapy of neonatal herpes simplex virus infections. Clin. Perinatol. 1997, 24:267-283.
97. Anderson M.S., Abzug M.J. Hydrops fetalis: an unusual presentation of intrauterine herpes simplex virus infection. Pediatr. Infect. Dis. J. 1999, 18:837-839.
98. Malm G., Berg U., Forsgren M. Neonatal herpes simplex: clinical findings and outcome in relation to type of maternal infection. Acta Paediatr. 1995, 84:256-260.
99. Arvin A.M., et al. Neonatal herpes simplex infection in the absence of mucocutaneous lesions. J. Pediatr. 1982, 100:715-721.
100. Greenes D.S., et al. Neonatal herpes simplex virus infection presenting as fulminant liver failure. Pediatr. Infect. Dis. J. 1995, 14:242-244.
101. Lee W.S., et al. Neonatal liver transplantation for fulminant hepatitis caused by herpes simplex virus type 2. J. Pediatr. Gastroenterol. Nutr. 2002, 35:220-223.
102. Ford A., et al. A 10-day-old neonate with fulminant hepatitis. J. Paediatr. Child Health 2008, 44:471-472.
103. Golden S.E. Neonatal herpes simplex viremia. Pediatr. Infect. Dis. J. 1988, 7:425-427.
104. Gressens P., Martin J.R. HSV-2 DNA persistence in astrocytes of the trigeminal root entry zone: double labeling by in situ PCR and immunohistochemistry. J. Neuropathol. Exp. Neurol. 1994, 53:127-135.
105. Langlet C., et al. An uncommon case of disseminated neonatal herpes simplex infection presenting with pneumonia and pleural effusions. Eur. J. Pediatr. 2003, 162:532-533.
106. O'Riordan D.P., Golden W.C., Aucott S.W. Herpes simplex virus infections in preterm infants. Pediatrics 2006, 118:e1612-e1620.
107. Corey L., et al. Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet 1988, 1:1-4.
108. Kimberlin D.W. Herpes simplex virus infections of the central nervous system. Semin. Pediatr. Infect. Dis. 2003, 14:83-89.
109. Mizrahi E.M., Tharp B.R. A characteristic EEG pattern in neonatal herpes simplex encephalitis. Neurology 1982, 32:1215-1220.
110. O'Reilly M.A., O'Reilly P.M., de Bruyn R. Neonatal herpes simplex type 2 encephalitis: its appearances on ultrasound and CT. Pediatr. Radiol. 1995, 25:68-69.
111. Toth C., Harder S., Yager J. Neonatal herpes encephalitis: a case series and review of clinical presentation. Can. J. Neurol. Sci. 2003, 30:36-40.
112. Pelligra G., et al. Brainstem involvement in neonatal herpes simplex virus type 2 encephalitis. Pediatrics 2007, 120:e442-e446.
113. Kimura H., et al. Quantitation of viral load in neonatal herpes simplex virus infection and comparison between type 1 and type 2. J. Med. Virol. 2002, 67:349-353.
114. Gutman L.T., Wilfert C.M., Eppes S. Herpes simplex virus encephalitis in children: analysis of cerebrospinal fluid and progressive neurodevelopmental deterioration. J. Infect. Dis. 1986, 154:415-421.
115. Whitley R., et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. N. Engl. J. Med. 1991, 324:444-449.
116. Music S.I., Fine E.M., Togo Y. Zoster-like disease in the newborn due to herpes-simplex virus. N. Engl. J. Med. 1971, 284:24-26.
117. Nahmias A.J., Hagler W.S. Ocular manifestation of herpes simplex in the newborn (neonatal ocular herpes). Int. Ophthalmol. Clin. 1972, 12:191-213.
118. Cherry J.D., Soriano F., Jahn C.L. Search for perinatal viral infection: A prospective, clinical, virologic, and serologic study. Am. J. Dis. Child. 1968, 116:245-250.
119. Whitley R.J., Lakeman F. Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. Clin. Infect. Dis. 1995, 20:414-420.
120. Kimberlin D.W., et al. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J. Infect. Dis. 1996, 174:1162-1167.
121. Kimura H., et al. Detection of viral DNA in neonatal herpes simplex virus infections: frequent and prolonged presence in serum and cerebrospinal fluid. J. Infect. Dis. 1991, 164:289-293.
122. Troendle-Atkins J., Demmler G.J., Buffone G.J. Rapid diagnosis of herpes simplex virus encephalitis by using the polymerase chain reaction. J. Pediatr. 1993, 123:376-380.
123. Malm G., Forsgren M. Neonatal herpes simplex virus infections: HSV DNA in cerebrospinal fluid and serum. Arch. Dis. Child. Fetal. Neonatal. Ed. 1999, 81:F24-F29.
124. Weil A.A., et al. Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result. Clin. Infect. Dis. 2002, 34:1154-1157.
125. Kimberlin D.W. Neonatal herpes simplex infection. Clin. Microbiol. Rev. 2004, 17:1-13.
126. Smalling T.W., et al. Molecular approaches to detecting herpes simplex virus and enteroviruses in the central nervous system. J. Clin. Microbiol. 2002, 40:2317-2322.
127. Elion G.B., et al. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc. Natl. Acad. Sci. U. S. A. 1977, 74:5716-5720.
128. Whitley R.J., et al. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics 1980, 66:495-501.
129. Bryson Y.J., et al. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir: a randomized double-blind controlled trial in normal subjects. N. Engl. J. Med. 1983, 308:916-921.
130. Corey L., et al. Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy. J. Antimicrob. Chemother. 1983, 12(Suppl. B):79-88.
131. Saral R., et al. Acyclovir prophylaxis of herpes-simplex-virus infections. N. Engl. J. Med. 1981, 305:63-67.
132. Whitley R.J., et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N. Engl. J. Med. 1986, 314:144-149.
133. Hintz M., et al. Neonatal acyclovir pharmacokinetics in patients with herpes virus infections. Am. J. Med. 1982, 73(1A):210-214.
134. Yeager A.S. Use of acyclovir in premature and term neonates. Am. J. Med. 1982, 73(1A):205-209.
135. Kimberlin D.W., et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001, 108:230-238.
136. American Academy of Pediatrics Herpes simplex. Red Book 2009 Report of the Committee on Infectious Diseases 2009, 363-373. American Academy of Pediatrics, Elk Grove Village, IL. 28th ed. L.K. Pickering, C.J. Baker, D.W. Kimberlin, S.S. Long (Eds.).
137. Long S.S. In defense of empiric acyclovir therapy in certain neonates. J. Pediatr. 2008, 153:157-158.
138. Kimberlin D.W. When should you initiate acyclovir therapy in a neonate?. J. Pediatr. 2008, 153:155-156.
139. Nyquist A.C., et al. Acyclovir-resistant neonatal herpes simplex virus infection of the larynx. J. Pediatr. 1994, 124:967-971.
140. Oram R.J., et al. Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate. J. Infect. Dis. 2000, 181:1458-1461.
141. Levin M.J., et al. Development of acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum. Pediatr. Infect. Dis. J. 2001, 20:1094-1097.
142. Rabalais G.P., et al. Antiviral susceptibilities of herpes simplex virus isolates from infants with recurrent mucocutaneous lesions after neonatal infection. Pediatr. Infect. Dis. J. 1989, 8:221-223.
143. Kimberlin D., et al. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr. Infect. Dis. J. 1996, 15:247-254.
144. Tiffany K.F., et al. Improved neurodevelopmental outcomes following long-term high-dose oral acyclovir therapy in infants with central nervous system and disseminated herpes simplex disease. J. Perinatol. 2005, 25:156-161.
145. Fonseca-Aten M., et al. Herpes simplex virus encephalitis during suppressive therapy with acyclovir in a premature infant. Pediatrics 2005, 115:804-809.
146. Kohl S., et al. Effect of intravenously administered immune globulin on functional antibody to herpes simplex virus in low birth weight neonates. J. Pediatr. 1989, 115:135-139.
147. Whitley R.J. Neonatal herpes simplex virus infections. Is there a role for immunoglobulin in disease prevention and therapy. Pediatr. Infect. Dis. J. 1994, 13:432-438. discussion 438-439.
148. Cone R.W., et al. Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women. JAMA 1994, 272:792-796.
149. Hardy D.A., et al. Use of polymerase chain reaction for successful identification of asymptomatic genital infection with herpes simplex virus in pregnant women at delivery. J. Infect. Dis. 1990, 162:1031-1035.
150. Watts D.H., et al. A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery. Am. J. Obstet. Gynecol. 2003, 188:836-843.
151. Andrews W.W., et al. Valacyclovir therapy to reduce recurrent genital herpes in pregnant women. Am. J. Obstet. Gynecol. 2006, 194:774-781.
152. Prober C.G. Management of the neonate whose mother received suppressive acyclovir therapy during late pregnancy. Pediatr. Infect. Dis. J. 2001, 20:90-91.
153. Tita A.T., Grobman W.A., Rouse D.J. Antenatal herpes serologic screening: an appraisal of the evidence. Obstet. Gynecol. 2006, 108:1247-1253.